Clinical Trial Update: From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis [NA]

View source ↗

Summary

This clinical trial from Nantes University Hospital investigates how genetic and transcriptomic factors contribute to poor outcomes in multiple sclerosis. The s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Snippet

Sponsor: Nantes University Hospital | Conditions: Multiple Sclerosis | NA | Status: RECRUITING